Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rice bran oil (RBO) is a nutrient-dense oil extracted from the outer layer of rice grains, containing a complex mixture of bioactive compounds such as gamma-oryzanol, phytosterols, and vitamin E isomers (tocopherols and tocotrienols). Investigated by Indonesia University (Universitas Indonesia) for its therapeutic potential in metabolic health, RBO functions as a multi-mechanistic nutritional intervention. It is primarily studied for its ability to improve glycemic control, enhance antioxidant capacity, and improve lipid profiles in patients with type 2 diabetes mellitus. Its effects are mediated through the modulation of cholesterol synthesis, upregulation of LDL receptors, and reduction of oxidative stress. RBO is categorized as a dietary supplement or nutraceutical rather than a conventional pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on rice bran oil.